Optimizing Decision-Making in CLL in an Era of Novel Agents

A comprehensive educational program featuring expert insight commentaries an Interactive Treatment Decision Support tool and a series of microeducation modules to fortify your practice in managing patients with CLL.

Share

Program Content

No activities added yet

No activities added yet

Supporters

Supported by educational grants from

AbbVie Inc.

AstraZeneca

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Pharmacyclics an AbbVie Company

Partners

CLL Society

ProCE Banner